Breaking News, Promotions & Moves

Paragon Strengthens Leadership Team

John Mosack head GMP mfg. at Baltimore site; Adam Sachs to lead program mgmt. and client alliance; Deborah Wild is chief quality and reg. affairs officer

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Paragon Bioservices, the private equity-backed biologics contract development and manufacturing organization (CDMO) who was recently acquired by Catalent, has appointed John Mosack as the vice president of manufacturing for its clinical through commercial-scale gene therapy facility in Baltimore, MD. Additionally, Paragon has appointed Adam Sachs as the vice president of program management and strategic client alliance to further support its customers throughout the life cycle of their product. ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters